Seamens’ Sign: a novel electrocardiogram prediction tool for left ventricular hypertrophy

ABSTRACT:

Introduction

Patients with left ventricular hypertrophy (LVH) diagnosed by electrocardiogram (ECG) have increased mortality and higher risk for life-threatening cardiovascular disease. ECGs offer an opportunity to identify patients with increased risk for potential risk-modifying therapy. We developed a novel, quick, easy to use ECG screening criterion (Seamens’ Sign) for LVH. This new criterion was defined as the presence of QRS complexes touching or overlapping in two contiguous precordial leads.

Methods

This study was a retrospective chart review of 2,184 patient records of patients who had an ECG performed in the emergency department and a transthoracic echocardiogram performed within 90 days. The primary outcome was whether Seamens’ Sign was noninferior in confirming

SUBMITTER: Walker P 

PROVIDER: S-EPMC9165589 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature